Pill Connect expands its team with the appointment of Richard Hall as Director of Quality

Pill Connect (formerly known as Elucid Mhealth), a world leader in medicine adherence monitoring and data capture on patient compliance, has expanded its team with the appointment of Richard Hall as Director of Quality. This follows the recent successful funding raise involving the investment serial entrepreneur Jonathan Milner, Catapult Ventures and Shallcross Partners and is the next step as Pill Connect moves towards commercialisation.

Richard has 27 years’ experience of Quality Management and New Product Development within the medical device industry. As founder and Director of QMS Consultancy Ltd Richard has helped 50+ companies worldwide to achieve their quality and regulatory goals, accelerating their route to market. Richard has lectured at Imperial College London and spoken at Oxford, Manchester and Liverpool universities as well as The National Physics Laboratory and multiple accelerators throughout the UK. As a trained Lead Auditor himself, Richard has helped his clients pass 72 Notified Body audits and understands what is required for a successful ISO 13485 & MDSAP assessment. Richard has also written product technical files gaining the CE mark for multiple devices.

CEO of Pill Connect James Burnstone Commented “We are delighted that Richard has joined our team as Director of Quality. His unique approach, vast knowledge and extensive expertise in this area has allowed us to implement a comprehensive ISO 13485 QMS in just one month, enabling us to move forward with our proven technology into the commercial phase of development. Throughout the whole implementation experience, Richard has been a pleasure to work with and we anticipate and look forward to a long and productive relationship with him.”